Literature DB >> 23492644

Assessment of donor biopsies.

Helmut Hopfer1, Éva Kemény.   

Abstract

PURPOSE OF REVIEW: To provide an up-to-date overview about the assessment of donor biopsies and to discuss the current problems and chances of preimplantation biopsies for transplant allocation with a focus on the technical work up and the histological variables scored. RECENT
FINDINGS: Preimplantation biopsy results are the major reason for discarding procured extended donor criteria kidneys in the USA. There is neither a consensus on the work up, nor the reporting of preimplantation donor biopsies, nor the importance of the biopsy findings in the process of allocation. The best available data have been collected in the context of single vs. double kidney transplantation. A clinical risk factor score may help to define kidneys when a preimplantation biopsy is warranted. Punch biopsies using a skin punch device appear to be a reasonable alternative for surgeons fearing needle biopsies.
SUMMARY: Donor biopsies are very useful as zero-hour biopsies establishing baseline information for comparison with subsequent transplant biopsies. As none of the histological variables and scores provides perfect prediction, preimplantation biopsy results have to be interpreted in the context of all available donor and recipient information.

Entities:  

Mesh:

Year:  2013        PMID: 23492644     DOI: 10.1097/MOT.0b013e3283607a6e

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  7 in total

Review 1.  German recommendations for pretransplantation donor kidney biopsies.

Authors:  Przemyslav Pisarski; Christina Schleicher; Ingeborg Hauser; Jan U Becker
Journal:  Langenbecks Arch Surg       Date:  2016-03-19       Impact factor: 3.445

2.  The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant.

Authors:  Bertram L Kasiske; Darren E Stewart; Bipin R Bista; Nicholas Salkowski; Jon J Snyder; Ajay K Israni; Gretchen S Crary; John D Rosendale; Arthur J Matas; Francis L Delmonico
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 8.237

3.  Reproducibility of Deceased Donor Kidney Procurement Biopsies.

Authors:  S Ali Husain; Kristen L King; Ibrahim Batal; Geoffrey K Dube; Isaac E Hall; Corey Brennan; M Barry Stokes; R John Crew; Dustin Carpenter; Hector Alvarado Verduzco; Raphael Rosen; Shana Coley; Eric Campenot; Dominick Santoriello; Adler Perotte; Karthik Natarajan; Vivette D D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz; Sumit Mohan
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-23       Impact factor: 8.237

4.  Procurement Biopsies in the Evaluation of Deceased Donor Kidneys.

Authors:  Dustin Carpenter; S Ali Husain; Corey Brennan; Ibrahim Batal; Isaac E Hall; Dominick Santoriello; Raphael Rosen; R John Crew; Eric Campenot; Geoffrey K Dube; Jai Radhakrishnan; M Barry Stokes; P Rodrigo Sandoval; Vivette D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz; Sumit Mohan
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-25       Impact factor: 8.237

Review 5.  A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques.

Authors:  Natalia Warmuzińska; Kamil Łuczykowski; Barbara Bojko
Journal:  J Clin Med       Date:  2022-01-18       Impact factor: 4.241

6.  The Independent Effects of Procurement Biopsy Findings on 10-Year Outcomes of Extended Criteria Donor Kidney Transplants.

Authors:  Darren E Stewart; Julia Foutz; Layla Kamal; Samantha Weiss; Harrison S McGehee; Matthew Cooper; Gaurav Gupta
Journal:  Kidney Int Rep       Date:  2022-05-30

7.  Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival.

Authors:  Isaac E Hall; Chirag R Parikh; Bernd Schröppel; Francis L Weng; Yaqi Jia; Heather Thiessen-Philbrook; Peter P Reese; Mona D Doshi
Journal:  Transplant Direct       Date:  2018-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.